Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
404.07
+4.89 (1.23%)
At close: Jun 12, 2026, 4:00 PM EDT
404.30
+0.23 (0.06%)
After-hours: Jun 12, 2026, 7:28 PM EDT

Elevance Health Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Cash & Equivalents
9,6579,4918,7138,5607,5008,2887,8666,4976,2266,52610,9199,99110,1427,3878,8726,4566,1614,8805,4905,258
Short-Term Investments
27,41626,62427,50326,23226,15226,39330,06729,49430,04129,84327,97628,29328,02826,90527,02927,33727,88128,14828,46727,594
Cash & Short-Term Investments
37,07336,11536,21634,79233,65234,68137,93335,99136,26736,36938,89538,28438,17034,29235,90133,79334,04233,02833,95732,852
Cash Growth
10.17%4.13%-4.53%-3.33%-7.21%-4.64%-2.47%-5.99%-4.99%6.06%8.34%13.29%12.13%3.83%5.73%2.86%-9.25%7.47%14.08%4.24%
Accounts Receivable
16,62315,23514,65715,91915,60513,05512,34413,33713,17312,46011,63911,32712,03211,74610,55510,60111,3289,6919,3579,439
Other Receivables
6,1676,3077,6927,2066,5766,0166,0555,8815,1205,4055,2935,1964,6784,2983,6513,6003,3343,7493,4503,246
Total Trade Receivables
22,79021,54222,34923,12522,18119,07118,39919,21818,29317,86516,93216,52316,71016,04414,20614,20114,66213,44012,80712,685
Other Current Assets
7,1695,3445,2135,4075,2885,1906,5147,0656,3885,7955,3584,9364,9435,2815,4965,6615,1934,6545,1404,701
Total Current Assets
67,03263,00163,77863,32461,12158,94262,84662,27460,94860,02961,18559,74359,82355,61755,60353,65553,89751,12251,90450,238
Net Property, Plant & Equipment
4,6574,6794,6574,6414,6174,6524,5054,4504,4514,3594,2484,5474,4184,3164,1974,0903,9863,9193,8353,733
Other Intangible Assets
11,09311,20011,32711,49011,94012,09410,32510,44710,71010,27310,49110,70310,91510,31510,53610,76210,58810,61510,74910,540
Goodwill
28,34028,34428,45128,36828,42028,27725,96725,96225,94725,31725,29125,27425,27324,38324,38124,36724,25124,22824,18424,399
Long-Term Investments
12,12311,96011,75911,55311,22710,78410,2877,6597,5936,9836,9346,7686,7546,4376,1386,0015,9615,8575,5845,498
Other Long-Term Assets
2,5822,3102,7772,5622,3922,1402,6032,1962,2451,9672,3292,1331,8571,6872,1712,0021,8031,7191,8041,689
Total Assets
125,827121,494122,749121,938119,717116,889116,533112,988111,894108,928110,478109,168109,040102,755103,026100,877100,48697,46098,06096,097
Accounts Payable
6,2097,3226,0857,2787,1316,9276,2555,7605,6586,9105,9835,0334,8735,6074,9635,8505,4934,9705,9605,598
Short-Term Debt
7241501803602503653602251,575225-265265265265175275275175175
Current Portion of Long-Term Debt
3501,0997491,6481,6431,6492,1002,9002,9001,649799--1,5002,2492,2483,0971,599849849
Unearned Revenue
1,7591,4931,8311,5611,6401,5081,7931,4811,4741,4024,3324,4584,3941,1123,7029711,2101,1539541,081
Other Current Liabilities
36,26730,97132,03332,98732,03430,13231,52531,44732,72731,60532,22331,81532,35731,21230,10830,06429,65826,88827,22426,091
Total Current Liabilities
45,30941,03540,87843,83442,69840,58142,03341,81344,33441,79143,33741,57141,88939,69641,28739,30839,73334,88535,16233,794
Long-Term Debt
30,76830,79731,17328,17828,11029,21824,68824,56121,97623,24624,04524,85925,20122,34921,25821,16519,88321,15721,76122,217
Other Long-Term Liabilities
5,7085,6366,6166,0756,2895,6645,9334,3174,8744,4864,5574,4264,4904,3804,4384,5374,8395,2905,3295,040
Total Long-Term Liabilities
36,47636,43337,78934,25334,39934,88230,62128,87826,85027,73228,60229,28529,69126,72925,69625,70224,72226,44727,09027,257
Total Liabilities
81,78577,46878,66778,08777,09775,46372,65470,69171,18469,52371,93970,85671,58066,42566,98365,01064,45561,33262,25261,051
Preferred Stock
---------0----------
Common Stock
22222222222222222222
Additional Paid-in Capital
8,8458,9388,9088,9318,8668,9119,1059,0018,8838,8688,8308,7618,6979,0849,1699,1349,1519,1489,1389,109
Accumulated Other Comprehensive Income
-741-451-543-760-911-1,147-489-1,387-1,365-1,313-2,512-2,166-2,050-2,490-2,784-2,149-1,236-178-103-17
Retained Earnings
35,79635,39335,58635,54934,54633,54935,15734,57533,08831,74932,10331,60830,70729,64729,60428,82528,05827,08826,70025,874
Total Common Shareholders' Equity
43,90243,88243,95343,72242,50341,31543,77542,19140,60839,30638,42338,20537,35636,24335,99135,81235,97536,06035,73734,968
Minority Interest
1401441291291171111041061029911610710487525556687178
Shareholders' Equity
44,04244,02644,08243,85142,62041,42643,87942,29740,71039,40538,53938,31237,46036,33036,04335,86736,03136,12835,80835,046
Total Liabilities & Equity
125,827121,494122,749121,938119,717116,889116,533112,988111,894108,928110,478109,168109,040102,755103,026100,877100,48697,46098,06096,097
Total Debt
31,84232,04632,10230,18630,00331,23227,14827,68626,45125,12024,84425,12425,46624,11423,77223,58823,25523,03122,78523,241
Net Cash (Debt)
5,2314,0694,1144,6063,6493,44910,7858,3059,81611,24914,05113,16012,70410,17812,12910,20510,7879,99711,1729,611
Net Cash Growth
43.35%17.98%-61.85%-44.54%-62.83%-69.34%-23.24%-36.89%-22.73%10.52%15.85%28.96%17.77%1.81%8.57%6.18%-24.45%-6.55%25.20%-4.27%
Net Cash Per Share
23.7318.3418.3920.4016.0614.9246.2735.5841.9147.7159.4155.3453.0042.2050.0841.9344.1440.7245.4138.85
Book Value
43,90243,88243,95343,72242,50341,31543,77542,19140,60839,30638,42338,20537,35636,24335,99135,81235,97536,06035,73734,968
Book Value Per Share
199.19197.84196.48193.63187.07178.78187.79180.77173.39166.69162.47160.66155.84150.26148.60147.13147.20146.88145.27141.34
Tangible Book Value
4,4694,3384,1753,8642,1439447,4835,7823,9513,7162,6412,2281,1681,5451,0746831,1361,21780429
Tangible Book Value Per Share
20.2819.5618.6617.119.434.0832.1024.7716.8715.7611.179.374.876.414.432.814.654.963.270.12
SEC Filings: 10-K · 10-Q